Total Payments
$11,768
2024 Payments
$3,272
Companies
56
Transactions
731
Medicare Patients
10,385
Medicare Billing
$466,305
Payment Breakdown by Category
Food & Beverage$11,754 (99.9%)
Education$13.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,754 | 730 | 99.9% |
| Education | $13.89 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,692 | 119 | $0 (2024) |
| ABBVIE INC. | $1,415 | 105 | $0 (2024) |
| Lilly USA, LLC | $995.22 | 57 | $0 (2024) |
| PFIZER INC. | $752.92 | 46 | $0 (2024) |
| Amgen Inc. | $597.35 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $570.91 | 37 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $551.19 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $507.08 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $431.30 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $372.48 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,272 | 171 | Lilly USA, LLC ($336.01) |
| 2023 | $2,961 | 173 | ABBVIE INC. ($390.05) |
| 2022 | $2,470 | 164 | Novo Nordisk Inc ($377.89) |
| 2021 | $2,375 | 175 | Novo Nordisk Inc ($398.30) |
| 2020 | $689.81 | 48 | Novo Nordisk Inc ($246.72) |
All Payment Transactions
731 individual payment records from CMS Open Payments — Page 28 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/21/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Bone Health | ||||||
| 01/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Diabetes | ||||||
| 01/14/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: VACCINES | ||||||
| 01/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: RESPIRATORY | ||||||
| 01/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Diabetes | ||||||
| 01/08/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Neuroscience | ||||||
| 01/07/2021 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: Insulin Pump | ||||||
| 01/05/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: Diabetes | ||||||
| 12/30/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: NEUROLOGY | ||||||
| 12/23/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Obesity | ||||||
| 12/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 12/10/2020 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: DIABETES | ||||||
| 12/05/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Diabetes | ||||||
| 12/01/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 11/24/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Diabetes | ||||||
| 11/24/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: Obesity | ||||||
| 11/20/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: UROLOGY | ||||||
| 11/17/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 11/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Diabetes | ||||||
| 11/10/2020 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 11/10/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Bone Health | ||||||
| 11/06/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.01 | General |
| Category: Cardiovascular | ||||||
| 11/05/2020 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,977 | 4,136 | $269,531 | $136,362 |
| 2022 | 37 | 2,989 | 4,229 | $275,715 | $141,735 |
| 2021 | 36 | 2,650 | 3,479 | $227,470 | $121,985 |
| 2020 | 29 | 1,769 | 2,229 | $138,314 | $66,224 |
Total Patients
10,385
Total Services
14,073
Medicare Billing
$466,305
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 293 | 581 | $98,770 | $46,198 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 288 | 288 | $50,400 | $35,041 | 69.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 115 | 116 | $12,180 | $8,337 | 68.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 167 | 196 | $13,720 | $5,686 | 41.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 297 | 470 | $11,750 | $4,861 | 41.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 272 | 348 | $12,528 | $4,553 | 36.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 283 | 491 | $6,383 | $4,124 | 64.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 119 | 120 | $3,840 | $3,523 | 91.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 297 | 456 | $7,296 | $3,470 | 47.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 153 | 194 | $6,790 | $3,193 | 47.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $5,396 | $2,966 | 55.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $3,695 | $2,157 | 58.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 109 | 198 | $4,554 | $1,866 | 41.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $2,310 | $1,439 | 62.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,160 | $1,194 | 55.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 22 | 25 | $3,125 | $1,011 | 32.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 47 | 47 | $2,068 | $889.24 | 43.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 49 | 58 | $4,060 | $857.24 | 21.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 47 | 54 | $3,618 | $778.14 | 21.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $855.00 | $557.84 | 65.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 67 | 90 | $2,790 | $509.40 | 18.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 67 | 92 | $2,576 | $467.36 | 18.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 16 | 18 | $990.00 | $455.22 | 46.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $1,331 | $392.90 | 29.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 21 | 21 | $924.00 | $378.42 | 41.0% |
About Dr. Michael Langan, MD
Dr. Michael Langan, MD is a Internal Medicine healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770618688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Langan, MD has received a total of $11,768 in payments from pharmaceutical and medical device companies, with $3,272 received in 2024. These payments were reported across 731 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,754).
As a Medicare-enrolled provider, Langan has provided services to 10,385 Medicare beneficiaries, totaling 14,073 services with total Medicare billing of $466,305. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Westerville, OH
- Active Since 02/22/2007
- Last Updated 03/04/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770618688
Products in Payments
- Ozempic (Drug) $903.81
- UBRELVY (Drug) $621.46
- JARDIANCE (Drug) $612.64
- XARELTO (Drug) $570.91
- MOUNJARO (Drug) $506.07
- EVENITY (Biological) $407.77
- VRAYLAR (Drug) $376.76
- NURTEC ODT (Drug) $360.05
- ELIQUIS (Drug) $354.03
- Rybelsus (Drug) $324.12
- FARXIGA (Drug) $322.75
- QULIPTA (Drug) $309.81
- Kerendia (Drug) $308.67
- GVOKE PFS (Drug) $264.88
- GVOKE HYPOPEN (Drug) $242.20
- LEQVIO (Drug) $226.73
- Wegovy (Drug) $199.34
- Korlym (Drug) $192.43
- Cologuard Collection Kit (Device) $183.42
- UNITHROID (Drug) $172.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Westerville
Nina Deep, M.d, M.D
Internal Medicine — Payments: $649,280
Internal Medicine $649,280
Dr. Sunil Nayyar, M.d, M.D
Internal Medicine — Payments: $68,290
Internal Medicine $68,290
James Dorado, M.d, M.D
Internal Medicine — Payments: $17,133
Internal Medicine $17,133
Kevin Donnelly, M. D, M. D
Internal Medicine — Payments: $16,783
Internal Medicine $16,783
Ian Wilson, Md, MD
Internal Medicine — Payments: $15,810
Internal Medicine $15,810
Anindya Sen, M.d, M.D
Internal Medicine — Payments: $10,128
Internal Medicine $10,128